Study Reveals Elevated Risk of Aspiration Complications During Surgery in GLP-1 Drug Users
A UK multicenter study of nearly 47,000 surgical patients found that those taking glucagon-like peptide-1 receptor agonists experienced pulmonary aspiration or regurgitation at a rate of 1.41%, compared to 0.12% in patients not using these medications. The increased risk was particularly pronounced during emergence from anesthesia, suggesting a need for specialized perioperative management protocols. Researchers call for additional prospective investigations to identify interventions that could reduce these serious complications in this growing patient population.
The study examined nearly 47,000 surgical patients across 119 UK hospitals, finding that roughly 3% were taking GLP-1 medications at the time of their procedures. These drugs, commonly prescribed for diabetes and weight management, showed an approximately 11-fold increased odds of aspiration complications compared to non-users. The risk appeared most acute during anesthesia emergence—the critical phase when patients transition from unconsciousness to wakefulness—suggesting this specific window requires targeted preventive strategies.
Current perioperative protocols for GLP-1 patients lack standardization, with significant variation in how anesthesiologists manage medication cessation and airway procedures. Researchers emphasize the need for prospective trials to test specific interventions that could reduce these serious complications, particularly given the medication's growing prevalence in surgical populations.
As GLP-1 receptor agonist use expands globally for metabolic and weight-related conditions, these findings could influence surgical planning for millions of patients. Anesthesiologists may need revised guidelines for preoperative assessment and airway management in this population. Healthcare systems might face pressure to develop standardized protocols and training. Patients taking these medications could benefit from heightened awareness of perioperative risks, though the absolute complication rate remains relatively low, and further research may identify effective mitigation strategies.